Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | hypothetical protein | 0.0065 | 0.2497 | 0.7409 |
Schistosoma mansoni | hypothetical protein | 0.0067 | 0.2608 | 1 |
Echinococcus granulosus | Ankyrin | 0.0014 | 0.0006 | 0.0006 |
Echinococcus multilocularis | jun protein | 0.0082 | 0.337 | 0.337 |
Echinococcus granulosus | jun protein | 0.0082 | 0.337 | 0.337 |
Schistosoma mansoni | retinoblastoma-binding protein 4 (rbbp4) | 0.0014 | 0.0006 | 0.0023 |
Loa Loa (eye worm) | hypothetical protein | 0.008 | 0.3258 | 1 |
Brugia malayi | bZIP transcription factor family protein | 0.0082 | 0.337 | 1 |
Echinococcus multilocularis | nuclear factor of activated T cells 5 | 0.0216 | 1 | 1 |
Onchocerca volvulus | 0.0065 | 0.2497 | 0.5 | |
Schistosoma mansoni | jun-related protein | 0.0067 | 0.2608 | 1 |
Echinococcus multilocularis | Ankyrin | 0.0014 | 0.0006 | 0.0006 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0082 | 0.337 | 0.337 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0082 | 0.337 | 0.337 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CyD50 (ADMET) | > 200 ug ml-1 | Cytotoxic dose at which 50% growth of normal cells is inhibited | ChEMBL. | 1847431 |
ED99 (functional) | 0 ug ml-1 | Minimum drug concentration at which 99% of the polio virus is inhibited; NA= not active | ChEMBL. | 1847431 |
MNTD (functional) | = 100 ug ml-1 | Maximal non-toxic dose (MNTD) that shows antiviral activity. | ChEMBL. | 1847431 |
RF (functional) | = 1 | The ratio of the poliovirus viral titer of the virus control (reduction factor) to the viral titer in the presence of the maximal non-toxic dose (RF MNTD) | ChEMBL. | 1847431 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.